EQL Pharma AB (FRA:7JK) Ending Cash Position : €1.81 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Ending Cash Position?

EQL Pharma AB's Ending Cash Position for the quarter that ended in Mar. 2024 was €1.81 Mil.

EQL Pharma AB's quarterly Ending Cash Position declined from Sep. 2023 (€1.76 Mil) to Dec. 2023 (€0.93 Mil) but then increased from Dec. 2023 (€0.93 Mil) to Mar. 2024 (€1.81 Mil).

EQL Pharma AB's annual Ending Cash Position increased from Mar. 2022 (€3.91 Mil) to Mar. 2023 (€3.96 Mil) but then declined from Mar. 2023 (€3.96 Mil) to Mar. 2024 (€1.81 Mil).

EQL Pharma AB Ending Cash Position Historical Data

The historical data trend for EQL Pharma AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Ending Cash Position Chart

EQL Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

Get a 7-Day Free Trial

0.95

2.61

3.91

3.96

1.81

EQL Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															3.96	2.13	1.76	0.93	1.81

EQL Pharma AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

EQL Pharma AB's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.921	+	0.888
	=	1.81

EQL Pharma AB's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	-2.085	+	3.894
	=	1.81

EQL Pharma AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB (FRA:7JK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

EQL:Sweden

Address

Stortorget 1, 3rd Floor, Lund, SWE, 222 23

Website

http://www.eqlpharma.com

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines